LIGAND PHARMACEUTICALS INC

Ligand Pharmaceuticals (LGNDZ) shows a clean 90-day record with zero cyber incidents and zero red-flag 8-K filings for bankruptcy, delisting, restatement, or officer departures. However, a quiet recent window does not eliminate underlying risks—dilution from equity issuance, debt refinancing activity, or regulatory headwinds may not surface until they materialize. The full $49 Report extends analysis to 12 months of SEC filings, calculates dilution risk scores, maps financing history, and flags AI-detected warning signals across 8-K context and capital structure that a 90-day snapshot cannot capture.